CorMedix Inc.
CRMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410098
No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding CorMedix Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 73 | 66 | −7 |
| Shares | 11.0M | 11.4M | +370.2K (+3.4%) |
| Value | $31.3M | $47.1M | +$15.8M (+50.6%) |
New holders (3)
Institutions that held CorMedix Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Advisor OS, LLC | 25,000 | $105.5K | 0.03% |
| Lighthouse Investment Partners, LLC | 16,377 | $69.1K | 0.01% |
| Tri Locum Partners LP | 13,812 | $58.0K | 0.03% |
Sold out (10)
Institutions that held CorMedix Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ergoteles LLC | 159,063 | $450.0K |
| XTX Topco Ltd | 74,538 | $211.0K |
| PDT Partners, LLC | 28,649 | $81.0K |
| Cubist Systematic Strategies, LLC | 28,000 | $79.0K |
| ExodusPoint Capital Management, LP | 15,298 | $43.0K |
| LMR Partners LLP | 13,517 | $38.0K |
| Riversedge Advisors, LLC | 11,373 | $32.0K |
| Avestar Capital, LLC | 10,000 | $28.0K |
| Antonetti Capital Management LLC | 200 | $1.00K |
| Royal Bank of Canada | 16 | $0 |